focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
Obelix, if you are talking about Porky (the £54 reference), then in my opinion you are bang out of order. He never left and has proved his substantial shareholding outside of this board.
The amount of work and research that he has completed and contributed towards over a sustained period of months does not stack with a fly-by-night ramper.
I'm sure you are correct about a few other people, but I have a great deal of respect for the piglet.
The news has yet to impact fully on the great majority of people in my opinion. That will happens tomorrow after various articles, analysis and comment. The buying in France was heavy towards the end of the day and that could impact over here tomorrow. This has still got legs and I think will build nicely again tomorrow. Just an opinion. Gla
Leec I bought a few in the 9’s as well as it seemed cheap at the time. Since averaged down quite a bit but I still believe you will come out ok. Many bios have no revenue. That is not the case here. Gla
Andecc, I really do believe that we will and more. It's going to be a steady run uphill over the next few months in my opinion, and then I believe that it will go on further as bits of the strategy come to pass. Don't also forgot the impact that a DHSC resolution could have. Hang on in there my friend!
I'm with you Porks. I fully expect this to go again tomorrow as the articles, analysts and even twats like Zak Mir add their ten-pennorth.
Lots of people are going to look at the market cap valuation tomorrow morning (even after todays rise), realise that this is delivering, and is sustainable and choke on their coffee before stabbing the buy button.
We have been shown the future today and that future is pretty bright.
I agree Poidster.
The 14/15% tick up today is very welcome and should (in any sane world) be the start of a steady recovery in the sp. I agree that the DHSC dispute is becoming slightly less important as the company demonstrate less and less reliance on them (but still important of course) and the situation is resolved. I actually thought GM handled that issue as well as he possibly could under the NDA restraints. Read between the words and they obviously have a working relationship.
I also give GM and his team credit for performing well under the pressure of the webinar and the live Q & A. They are not employed as professional presenters and not everyone feels comfortable with the spotlight on them (and some are better than others). I thought they were as straight-forward as they could be personally. I don't feel that anything that could be answered was dodged, simply that they were careful not to disclose stuff that should be in an RNS or that was commercially sensitive.
You all know that I am massively positive about Novacyt and believe that it is a bloody good place to have my money. My confidence has increased hugely off the back of what I have heard and read today. A happy bunny here!
Hamster "Hopefully the SP will get another boost when the US wake up."
I admire the sentiment but why? They have been able to buy since 8.00am this morning (as we are not on any US markets) and most of them will have no idea who Novacyt are anyway.
That's very fair 21ATS but it is where I see Novacyt starting to go as well. The fact is that they have moved from probably 90% dependence on DHSC to currently probably less than 10%.
It might not be through desire or design but it may actually be the best thing that could have happened whilst they are in a strong position to manage and cope with the tap being turned off in that department. Most rapid growth companies have an element of luck (like yours did) and Novacyt was also in the right place at the right time (unfortunate as the circumstances were with the pandemic).
They are in an incredibly strong position now. The worst possible scenario with DHSC is priced in and more. This share is undervalued many times at the current price. It has no debt, cash in the bank, a much more diverse client base and a shed full of non-covid related products now and in development. The bioinformatics side is not just covid-related. The world we now live in is going to required their services for the foreseeable future. The money is there for sorting DHSC, making timely and appropriate acquisitions/mergers and to secure a sustainable and profitable future. Add the continuing recruitment and the current pool of expertise and the sky is the limit.
I am very optimistic about this mid-cap in the making but that is only my opinion of course. GLA
Wonderful! And by some margin. No doubt plenty of traders cashing in but great volume and lots of substantial buys.
This is still stupidly and insanely undervalued (even with the worst case DHSC scenario) so god knows what would happen if that issue was resolved.
The webinar could easily give another substantial boost. GLA